Gujarat Themis Biosyn Limited Amends Articles of Association Post Shareholder Approval
Gujarat Themis Biosyn Limited shareholders approved an amendment to the Articles of Association via postal ballot on August 22, 2026. The change removes the requirement for a registered valuer's report for share price determination in Article 13(1), Clause (c).
The amendment pertains to internal governance and administrative procedures related to share pricing, with no direct or significant short-term impact on the company's financial performance or market standing.
The announcement details a procedural change in the company's Articles of Association, which does not have an immediate or direct financial impact on the company's operations or performance.
Gujarat Themis Biosyn Limited has announced an amendment to its Articles of Association (AOA), following a special resolution passed by its shareholders via postal ballot on August 22, 2026. The amendment specifically targets Article 13(1), Clause (c).
Previously, Clause (c) included a condition requiring the price of shares to be determined by a registered valuer or an approved valuer who would submit a valuation report. This condition has now been deleted.
Consequently, Article 13(1), Clause (c) will now read: "(c) Any persons, whether or not those persons include the persons referred to in clause (a) or clause (b) above, either for cash or for a consideration other than cash." This change removes the mandatory requirement for a valuation report for share price determination in certain scenarios.
What to do with a filing like this
Gujarat Themis Biosyn Limited filed this with the NSE as a statutory disclosure, categorised under corporate governance report. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Gujarat Themis Biosyn Limited. Read the original for the full detail.